Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma, Hardback Book

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma Hardback

Edited by Michael J. Murphy

Part of the Current Clinical Pathology series

Description

This book describes both the technologies used in the discovery of melanoma biomarkers and the clinical application of these biomarkers for diagnosis and staging of disease, determination of prognosis, treatment planning, monitoring of response to therapy, identification of novel therapeutic targets and drug development.

A broad range of biomarkers (DNA/chromosomal, mRNA, microRNA, mitochondrial DNA, epigenetic and protein) is outlined.

As therapies for melanoma become increasingly more target specific, the identification, validation and use of biomarkers will invariably play a greater role in the management of patients with this disease.

Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma is an essential resource for oncologists, dermatologists, dermatopathologists, general pathologists with an interest in melanoma, and melanoma researchers.

Information

  • Format: Hardback
  • Pages: 322 pages, 35 Tables, black and white; XIV, 322 p. 29 illus., 24 illus. in color.
  • Publisher: Humana Press Inc.
  • Publication Date:
  • Category: Oncology
  • ISBN: 9781607614326

£201.00

£172.45

 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Also in the Current Clinical Pathology series   |  View all